Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 51.76
-0.03 (-0.06%)
At close: Apr 29, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 7.21 billion as of April 29, 2026. Its market cap has increased by 71.94% in one year.
Market Cap
7.21B
Enterprise Value
6.23B
Revenue
354.91M
Ranking
n/a
PE Ratio
139.89
Stock Price
51.76
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 7.21B, a decrease of -30.89%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 7.21B | 29.25% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 7.22B |
| Jiangsu Aidea Pharmaceutical Group | 7.17B |
| Anhui Huaheng Biotechnology | 7.04B |
| Chengdu Kanghua Biological Products | 7.48B |
| Acrobiosystems | 7.60B |
| Wuhan Keqian Biology Co.,Ltd | 6.74B |
| Nanjing Vazyme Biotech | 7.91B |
| Daan Gene | 8.10B |